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Abstract 
Flow injection analysis (FIA) is an analytical chemical continuous-flow (CF) method which in 
contrast to traditional CF-procedures does not rely on complete physical mixing (homogenisation) 
of the sample and the reagent(s) or on attaining chemical equilibria of the chemical reactions 
involved. Exploiting controllable dispersion of the injected sample within the reagent-containing 
carrier stream and strictly reproducible timing of all events taking place, it is based on measuring 
transient signals, which not only implies very high sampling rates, but also, and most importantly, 
permits implementation of a number of novel methodologies which are not feasible when 
performed under batch conditions or by conventional CF-procedures. Demonstrated for selected 
bioanalytical and technological applications encompassing cellular and enzymatic assays as well as 
monitoring of culture media, the principles and operational characteristics of FIA are first outlined, 
and then its downscaled/miniaturized sequels, that is, sequential injection analysis (SIA) and lab-on-
valve (LOV), are detailed. Thus, in SIA the sample and reagents are, via the use of a multiposition 
valve and an attached syringe pump operated under full programmable control, aspirated 
sequentially and then propelled forward allowing the sample and reagent(s) to be intermixed and, if 
called for, subjected to appropriate treatments before analyte detection. This infers that merely 
minute sample/reagents volumes are consumed, hence leading to generation of small amounts of 
waste. In LOV this downscaling is taken further by using a small monolithic structure within which 
all sample manipulations and ultimate analyte detection under programmable control can be 
effected. Even bead-materials with different surface groups/characteristics, including live cells, can 
be handled and utilized as demonstrated. Because the syringe pump in SIA and LOV can be used 
for accurately aspirating, propelling or even stopping the flow, these modi operandi allow fully to 
exploit the interplay between the kinetics and the thermodynamics of the chemical reactions 
involved, so that there are no restrictions whatsoever as to the chemistries that can be implemented, 
even if they entail multi-step reactions. Representative bioanalytical examples of this interplay are 
presented.  
 
Key Words: Flow injection (FI); Sequential injection (SI); Lab-on-valve (LOV); Process control; 
Bioassays; culture media; enzyme; kinetics; thermodynamics. 
 
 
X.1 Introduction 
Introduced in 1975, flow injection analysis (FIA) was an entirely new approach to perform 
chemical analysis (1). While such assays for centuries had been based on thorough mixing of 
sample with appropriate reagent(s), and waiting for chemical equilibrium to be obtained (that is, 
both physical and chemical homogenization), FIA was, as illustrated in Fig. 1(a), founded on 
injection of a well defined volume of sample into an inert or reagent-containing carrier stream, to 
which additional reagents, if called for, could be added downstream, thereby accomplishing partial 
mixing of the components to promote chemical reaction, the result of which subsequently could be 
monitored by a suitable flow-though cell, which may continuously observe an absorbance, an 
electrode potential, or any other physical parameter as it changes on passage of the sample material 
through the flow cell. Thus, the physical and chemical homogenization, which, in fact, had been the 
key stones in batch assays and also in the then existing (predominantly clinical) automated 
analysers, were not any more necessary, which, in turn, opened up entirely new avenues to perform 
chemical assays, where non-steady state conditions could be exploited. The ensuing years have 
amply proven these advantages, as clearly evidenced in the large number of FIA publications which 
have been published, counting at the beginning of 2008 altogether more than 17.500, to which 
should be added ca. 20 dedicated monographs and hundreds of Ph.D.-theses (2). 
 
During its existence, FIA has undergone certain changes and modifications, i.e., it was in 1990 
supplemented by Sequential Injection Analysis (SIA), also termed the 2nd generation of FIA (3,4), 
and in 2000 by the Lab-on-Valve (LOV), the 3rd generation of FIA (5). Thus, the present chapter 
will focus on these three generations of FIA, their characteristics and their applications, that is, 
initially outlining the distinctive features of FIA as compared to conventional continuous flow 
analysis (CFA) and via selected examples demonstrate some of its unique capabilities, while in the 
following sections emphasis will be placed on the ensuing generations of FIA, detailing their 
distinct advantages (and limitations) as compared to FIA. In selecting the examples given, attention 
has been given to show the versatility of FIA and its sequels particularly within the biotechnological 
field, including process monitoring. What is of importance in the present context is to demonstrate 
that the FIA approach, besides allowing automation of chemical assays with high sampling 
frequencies and minute consumptions of sample and reagent solutions, offers potentials to 
implement novel applications. Or as one of these authors previously wrote in characterising FIA: 
"the ultimate test for an analytical approach is not that it can do better what can be done by other 
means, but that it allows us to do something that we cannot do in any other way" (6). And FIA does 
exactly that. The only limitation is simply our own ingenuity. 
 
 
X.2 Fundamentals of Flow Injection Analysis 
As mentioned above, FIA is based on injection, or insertion, of a discrete, well-defined volume of 
sample solution (usually 20-100 μl) into a flowing carrier stream. Yet as already verbalized in the 
very first FIA-publication it relies on two additional cornerstones, namely: (i) reproducible and 
precise timing of the manipulation that the injected sample zone is subjected to in the system, from 
the point of injection to the point of detection, that is, the so-called controlled, or rather controllable, 
dispersion. And (ii) the creation of a concentration gradient of the injected sample, providing a 
transient, but strictly reproducible readout of the recorded signal. The eventual peak shaped readout, 
as monitored by a suitable detection device, is therefore always the result of two kinetic processes 
which occur simultaneously, namely the physical process of zone dispersion and the superimposed 
chemical processes resulting from reaction between analyte and reagent species. It is the 
combination of these features that makes it unnecessary to achieve steady-state conditions, as are 
essential in conventional CFA. Any point on the path toward the steady-state signal is as good a 
measure as the steady-state itself, provided that this point can be reproduced repeatedly, and this is 
certainly feasible in FIA with its inherently exact timing. This, in turn, has not only allowed to 
perform chemical assays much faster, and hence facilitate higher sampling rates, than in 
conventional procedures, but more importantly it has permitted to implement procedures which are 
difficult, or, in fact, impossible, to effect by traditional means.  
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Being modular in its operational set-up, virtually any unit operation can be incorporated into an FIA 
system in order to facilitate the optimal manipulations and ultimate detection of the analyte. Thus, 
the sample might be subjected to appropriate pre-treatments to separate the analyte species from 
interfering constituents (e.g., by dialysis or extraction), it can be heated/cooled, suitable chemical 
reagents can be added downstream to facilitate the desired chemical reaction(s) under optimal 
conditions, and almost any detection device is amenable to be used. In biotechnological 
applications, sampling is performed by exploiting a sterile barrier for removal of suspended matter, 
high molecular weight species or cells (7). The immediate consequences of this sample pre-
treatment  is the effective stopping of any further metabolism in the collected sample and the 
feasibility to inject a preset volume of sample directly into the detection system without no need for 
further sample clean-up. The sterile barrier is usually composed of a flow-through concentric 
microdialysis probe operating under convective-controlled transport (8,9). The microdialysis probe 
can be introduced either directly into the reactor or implemented into an external by-pass loop in 
order to minimize membrane fouling. When monitoring parameters in fermentation broths, it is 
however important to reduce both residence time in the loop and the ratio of loop volume to 
working volume in the bioreactor to prevent any effect on the performance of the microbial culture 
in terms of substrate availability due to the recirculation process (10). It should be borne in mind 
that yields of flow-through dialysis are frequently below 15% wherefore dialysis modules/probes or 
filter probes have been tailored successfully to bioreactors for in-line dilution of target species 
(11,12).  
 
Moreover, since only one sample is handled at a time in FI set-ups, the inter-sample washout is 
efficient and there is no cross sample contamination. In addition, because the wash-to-sample ratio 
is high, the sample contact time with the detector is short, which is especially advantageous for 
biosensor applications, as the analytical reaction often reduces the life of the sensor (sensor wear-
off) (7).   
 
While much of the attention in using FIA (or just FI, to emphasise that it is a conceptual approach, 
in addition to a means of performing analysis) initially was set on the feasibility of achieving high 
sampling rates, as facilitated by exploiting transient rather than conventional steady-state signals, 
the focus was soon shifted to exploitation of the concentration gradient created, which, as a result of 
the axial and radial dispersion processes, in reality corresponds to an innumerable number of 
sequential liquid segments, representing all concentrations from zero to the maximum of the FI 
peak readout, each of which, as related to a fixed delay time (as measured from the time of 
injection), potentially can be used for the analytical readout. This, in turn, gave rise to a number of 
gradient methods (13) as briefly outlined in Table 1, among which especially should be highlighted 
the stopped-flow method (Fig. 2), which either can be used to gain increased reaction time without 
dilution (dispersion) of the injected sample, or, when stopping a part of the sample/reagent mixture 
within the flow-through cell, for sensitivity improvement as well as for measurement of reaction 
rates. The second approach has proven to be a very powerful tool in many contexts and 
implemented in the various generations of flow injection (14). Not the least for bioanalytical assays 
encompassing investigation of cellular activities (15,16) and enzymatic procedures for 
determination of both substrates and enzymatic activities (17,18), where the latter one traditionally 
has been very difficult to execute.  
 
Later followed the introduction of methods relying on detection by bio- and chemiluminescence, 
where alpha and omega is the inherent and accurate timing of the FI-manifold, thus allowing to 
relate the maximum intensity of the generated transient light emission to the analyte concentration 
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(see below). These very sensitive analytical procedures, which prior to the introduction of FI 
virtually were non-existent, have blossomed to the extent that more than 2000 publications have 
emerged in the scientific literature over the years, thus accounting for ca. 11.5% of all the published 
FI-papers (2). Essentially, these assays are all based on enzymatic conversion procedures, and these 
types of kinetic modus operandi are, in fact, some of the most frequently encountered ones. In the 
beginning primarily relying on the use of solubilised enzymes, but later predominantly via 
immobilised enzymes, taking advantage of the fact that the costly enzymes, even though they are 
participating in the reactions with the substrate, are not consumed and thus can be reused.  
 
Exploiting the precise and reproducible timing in FI, the formation of intermediate/metastable 
constituents, which, in contrast to the ultimately generated products, exhibit specifically attractive 
analytical characteristics, have been utilised to serve for the analytical readout (14), an approach 
that is totally impossible to make use of in a batch system. Among the many exciting novel 
techniques are also found the so-called kinetic discriminating schemes, where, even subtle, 
differences in the reaction rates of occurring chemical reactions judiciously are exploited (19,20) 
(see section below). 
  
 
X.2.1. Dispersion and dispersion coefficient 
The dispersion in an FI-system is quantified by the dispersion coefficient D, which is defined as the 
ratio of the concentrations of sample material before (Co) and after (C) the dispersion has taken 
place in that element of fluid that yields the analytical readout, that is: D = Co/C (14). The 
dispersion can be manipulated by the physical dimensions of the FI-manifold used (e.g., length and 
i.d. of tube, pumping rate and number of merging points), as dictated by the analytical task to be 
fulfilled. Thus limited dispersion (D = 1-2) is used when the injected sample is to be carried to a 
detector in undiluted form, that is, the FIA system serves as a means of rigorous and precise 
transport and sample presentation to the detection device (such as an ion-selective electrode or an 
atomic absorption spectrometer). Medium dispersion (D = 2-10) is employed when the analyte must 
mix and react with the carrier/reagent stream to form a product to be detected, while large 
dispersion (D > 10) is used only when the sample must be diluted to bring it within the dynamic 
measurement range of the detection device, which is imperative in a vast number of analyzers for 
determination of target species in cultivation media (7,11). Reduced dispersion (D < 1) implies that 
the concentration of the sample detected is higher than the concentration of the sample injected, that 
is, on-line preconcentration is effected (e.g., by means of liquid or by solid-phase extraction or by 
coprecipitation). The latter procedures have especially gained momentum for selective 
determination of ultra-low levels of metals acting as potential inhibitors of enzyme reactions (see 
section below on SI-LOV). 
 
X.3.Selected Bioanalytical Applications Exploiting FI 
In the following will be mentioned some bioassays where the conditions of the FI- system are 
manipulated so that the dispersion is optimal for the given purpose. As a good example of systems 
exploiting limited to small medium dispersion may serve the use of sensors (ion-selective electrodes 
or biosensors) (7,21). In potentiometry it is observed that many ion-selective electrodes (ISE) 
operated in the dynamic mode facilitate fast and reproducible readout. ISEs are, however, generally 
characterised by fairly long response times to reach steady-state conditions, and therefore it can be 
difficult to ascertain exactly when to make the readout by manual operation. In FI this decision is 
left entirely to the system, because the sample reaches the detector after a time governed exclusively 
by the manifold used. Besides, the well-known fact that many ISEs are more or less prone to 
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interference from other ions can in many cases be eliminated, or considerably reduced, when 
making the measurement under FI-conditions. Thus, by taking advantage of the short residence time 
and exposure time of the sample in the FI-system, it is often possible, via kinetic discrimination 
between the ion under investigation and the interfering species (which frequently exhibit longer 
response times), to improve the selectivity and hence the detection limit of the sensor.  
  
The same concept of manipulating the sample exposure time can be extended to more complex 
sensors such as enzyme sensors, in which a membrane containing one or more immobilized 
enzymes is placed in front of the active surface of a transducing element. The analyte is transported 
by diffusion into the membrane and here degraded enzymatically, forming a product which can then 
be sensed by the transducer. Flow-injection biosensors for bioreactor monitoring usually combine 
oxidase or dehydrogenase-linked enzymic reactions with amperometric detection of molecular 
oxygen depleted or hydrogen peroxide generated (22-24). A common configuration for single 
parameter measurement involves a sandwich-type membrane configuration with the enzyme 
embedded in the intermediate layer in order to minimize enzyme leaching and microbial attack 
while preventing reducing or oxidizing interfering species from reaching the electrode surface (21). 
Sequential or simultaneous multiparametric detection can be accomplished by the use of either 
various enzymic sensors in a parallel or series configuration (23) or integrated electrode arrays (25-
27), respectively. 
 
A condition for obtaining a linear relationship between the concentration of analyte and analytical 
signal is, however, that pseudo-first-order reaction conditions are fulfilled, that is, the concentration 
of converted analyte reaching the detector surface must be much smaller than the Michaelis-Menten 
constant. Since this constant for most enzyme systems is of the order of 1 mmol/L, and many 
sample matrices (e.g., substrates for culture broths) contain much higher analyte concentrations, the 
use of enzyme sensors in static (batch) systems often calls for complicated use of additional 
membrane layers aimed at restricting diffusion of analyte to the underlying enzyme layer, which in 
turn implies slow response, or, in case of electrochemical detectors, calls for chemically modified 
electrodes where the electron transfer is governed by appropriate mediators. 
 
However, when operated in FI, the degree of conversion can be simply adjusted by the time the 
analyte is exposed to the enzyme layer, and therefore the amount of converted analyte can be 
regulated directly by adjusting the flow rate of the FI-system (28). Thus in an FI-system, used for 
the determinations of glucose by means of an amperometric sensor incorporating glucose oxidase, it 
was shown (Fig. 3), that by increasing the flow rate from 0.5 to 1.0 mL/min the linear measuring 
range could readily be expanded from 20 to 40 mmol/L glucose (28). Of course there is a price to be 
paid for this convenience, and as seen on Fig. 2 it is that the sensitivity is slightly decreased. This 
approach has found much use in ensuing years. Thus, for instance Tsukatini and Matsumoto (29) 
have used it for the fluorometric determination of pyruvate, and in turn assay of acetate, citrate and 
L-lactate. 
 
Additionally, the exposure time can be exploited for kinetic discrimination, taking advantage of 
differences in diffusion rates of analyte and interfering species within the membrane layer of the 
electrode. This was very elegantly demonstrated in the above-mentioned system (28), where total 
spatial resolution of the signals due to glucose and paracetamol could be achieved, even when 
paracetamol was added at excessive levels. Besides, attention should be drawn to the fact that the 
operation of a (bio)sensor in the FI mode ensures a constant monitoring of the sensor itself, that is, 
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while the recorded signal is a measure of the concentration measured, the baseline readout indicates 
directly the stability of the sensor. 
 
In this context it should be mentioned that considering the diversity of the chemical and physical 
events that can be involved in the function of a biosensor, in addition to satisfying individually 
dictated reaction parameters, it is not surprising that operational compromises frequently have to be 
made for practical synchronization of all the processes required (30). Thus, the optimal pH used for 
the enzymatic degradation process might not (as is often the case) be identical to the preferential pH 
value for detection of the product generated. For example if a gas sensor covered with a membrane 
of glutaminase is employed for determination of L-glutamine, the measurement of the ammonia 
evolved will require a pH value 2-3 units higher that that of the enzymic reaction. Furthermore, and 
in order to implement functions such as periodic calibration, conditioning and possible regeneration 
of the biosensor, and, very importantly, to yield the freedom to select the optimum detection means, 
it is advantageous to use these devices in the FI-mode (31). Besides, utilization of biosensors in FI-
manifolds allows the sample to be modified/manipulated as required for execution of various unit 
operations such as separation, automatic dilution, or (bio)chemical derivatization prior to the final 
detection step. In fact, the ideal solution is to use an FI-system where the enzymatic degradation of 
the sample and the detection step are separated and can be individually optimised, that is, the entire 
system flow system is be considered as a biosensor/biosensing device (32). For the very same 
reasons, the emphasis on the development of biosensors has in recent years shifted from fabricating 
devices which can be used as probe sensors, similarly to the approach of ISEs in batch assays, to 
development of flow-through sensor systems. 
   
When applied in the FI-mode the use of immobilized enzymes offers not only the selectivity, 
economy and stability gained by immobilization, but also ensures that strict repetition, and hence a 
fixed degree of turnover from cycle to cycle, is maintained. Two types of reactors have been 
incorporated and evaluated in flow set-ups, namely, packed-bed reactors with the enzyme 
immobilised on controlled-pore glass (33-35), and wall-coated open tubular reactor with the 
enzyme attached to the inner surface of nylon tubing or silica-fused capillaries (36-38). The former 
one features larger surface area and therefore larger enzyme load per unit volume, yet progressively 
tighter packing of the reactor might lead to increased backpressure with the consequent 
deterioration of the analytical performance of the analyzer. Thus, whenever several enzymic 
reactions are involved, co-immobilization strategies are preferred over coupling of various reactors 
in series. Several examples are found in literature referring to biotechnological applications, mostly 
comprising the oxidase/peroxidase (35,39) or dehydrogenase/aminotransferase (34,40) pairs. Both 
optical and electrochemical detectors can be used to monitor the reaction(s). Thus, for 
dehydrogenases, involving NAD+/NADH, spectrophotometry (34,40) or fluorometry (29) is directly 
applicable, while for oxidases, which give rise to the generation of hydrogen peroxide, 
amperometric measurements or spectrophotometric detection of a chromogenic redox reagent can 
also be employed (35,39).  
 
In open reactors, the surface area per unit volume is orders of magnitude lower than that packed 
reactors and thus the enzyme load is much lower. Longer reactors are needed for attaining similar 
sensitivity, yet compromise should be taken to prevent undue sample/reaction product dispersion. 
The most relevant asset is the negligible flow impedance increase even after long operational 
protocols (41). Therefore, this alternative has found applications for monitoring high concentrations 
of dissolved substrate components, but also for products of bacteria or yeast cultivations when 
coupled to highly sensitive detection systems such as those involving luminol-based 
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chemiluminescence reactions (35,36). Analyte detection via chemiluminescence is particularly 
fascinating and attractive, not merely because of the potentially high sensitivity achieved, but the 
wide dynamic range of luminescent procedures and fairly simple instrumentation needed. 
Furthermore, luminescence has an added advantage over most optical procedures: as light is 
produced and measured only when sample is present, there is generally no problem with blanking. 
However, the radiation in luminescence reactions is most often emitted as a flash which rapidly 
decreases, and for this reason the conventional approach of quantification has been to integrate the 
intensity over a fixed period of time and relate this to the amount of analyte. It is obvious, however, 
that if the measurement of the intensity of light dE/dt can be made under precisely defined and 
reproducibly maintained conditions so that all samples are treated, physically and chemically, in 
exactly the same manner (i.e., the measurements can be taken repetitively at identical delay times ti, 
Fig. 4), it is possible directly to relate any dE/dt-value (and preferably the one corresponding to the 
maximum emission, Δt, Fig 4) to the analyte concentration. This is feasible by means of FI, and 
therefore the combination of luminescence and FI has, in fact, revolutionised the application of bio- 
and chemiluminescence as analytical chemical detection procedures (42).  
  
Numerous applications of enzyme assays in FI have been reported, advantage being taken of the 
fact that these components constitute the selective link in the analytical chain which therefore 
becomes selective overall (43). Some recent reviews contain extensive up-to-date of FI-enzymic 
assays and FI-biosensing (7,21). Seen in this context, it is apparent that FI not only constitutes a 
complimentary facility to (bio)sensors, but in many cases offers itself as an attractive alternative.  
 
 
X.4 The Role of FI for Process Analysis/Monitoring 
In emphasising the many analytical chemical possibilities that FI offers, it is of interest to end this 
section by drawing attention to an application of this concept that at an early stage promised to 
become very important, that is, its use for monitoring purposes notably in areas such as process 
control/development and optimisations. Traditionally, most industrial processes have been surveyed 
off-line in the laboratory after withdrawal of separate samples. However, for an efficient process 
monitoring and control, the time delay, the limited reliability, and the man power needed for 
analysis of a large number of samples are crucial parameters. Already in 1982, the first paper on 
utilisation of FI for process control appeared (44), and in their FI-monograph Ruzicka and Hansen 
(14) predicted that FI would turn out to play a major role in this area, because it potentially offered 
a number of advantages, the most significant ones being: (a) Because every FI readout inherently 
consists of a peak that goes from the baseline, through a maximum, and back to the baseline again, 
one can not only monitor the analyte species via the reaction taking place in the manifold (i.e., via 
the peak maximum), but one can at the same time control the performance of the analytical system 
itself (i.e., by the baseline); (b) FI allows occasional recalibrations or updates/checks of the 
calibration curve at will, that is, standards can be injected at any time desired, which is a necessity 
particularly if very complex samples are at hand; (c) FI is very economical in sample consumption - 
which not the least is important when used in pilot plant scale experiments - even if the procedure 
applied calls for the use of a reversed FIA assay (rFIA, i.e., where the reagent is injected into the 
sample); and (d) FI permits appropriate pretreatment of the sample prior to analyte detection, that is, 
subjecting the sample to dialysis, filtration, extraction or other separation procedures, thereby 
eliminating potentially interfering species.  
 
The ideal solution for process monitoring would be, of course, to implement an in situ totally 
selective (in fact, “specific”) detection device (sensor). As this is virtually impossible (a pH 
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electrode and a thermometer possibly constituting the only exceptions coming close to be meet this 
criteria), and considering the remarks stated above, near real-time monitoring must necessarily be 
made in an ex-situ set-up (7). Facilitating this has in the literature been called by several names, 
such as “on-line” or “in-line” (which in this context obviously are wrong). Since a sample must be 
in some manner withdrawn from the system (e.g., using microdialysis probes) and then analysed, 
the proper tag would be either “off-line” or “at-line” detection. When using FI as the analysis 
system, the latter term is preferential, because it implies that the determination is made at the site 
and in as close as possible to real-time.  
 
In 2001 and 2003 Workman et al. (45,46) presented comprehensive compilations of FI-literature for 
process control applications. Although some additional papers have appeared in the literature since 
then (e.g., (35), it is evident that FI has not played the role expected in this field. Seen in retrospect 
the reason for this is simply that the commercial (and homemade) FI apparatus available often was 
designed for the laboratory environment, where continuous supervision of its function was a norm, 
and therefore was not sufficiently reliable for application in industrial settings (47). In fact, it took 
two decades and the development of sequential injection analysis to resurrect the idea in earnest, 
that is, by replacing the peristaltic pumps with a single syringe pump, the injection valve with a 
multiposition valve, continuous flow with reagent saving programmable flow, and human 
supervision with computer control, that is, the advent sequential injection analysis (SIA or SI) (4). 
Autonomous SI systems are now deployed in industry as well as in remote locations to provide 24/7 
(twenty four hours/seven days a week) monitoring of variety of analytes ranging from 
spectrophotometric determinations of dyes to fluorescence/enzymatic assays of bacteria coli (48).  
 
 
X.5 Fundamentals of Sequential Injection Analysis  
While most FI-procedures employ continuous, uni-directional pumping of carrier and reagent 
streams irrespective of whether a sample is injected or not, which from the point of view of reagent 
consumption is a drawback, sequential injection analysis (SIA or just SI) is based on using 
programmable, bi-directional discontinuous flow as precisely coordinated and controlled by a 
computer (3,4)). A sketch of a typical SI-manifold is reproduced in Fig. 1(b). 
 
The core of the system is a multi-position selection valve (here shown as a 6-port valve), furnished 
with a central rotary communication channel (CC) that can be made to address each of the 
peripheral ports (1-6), and a central communication line (CL) which, via a holding coil (HC), is 
connected to a syringe pump operating as the liquid driver. By directing the central communication 
channel to the individual ports, well-defined and precisely metered sample and reagent zones 
(typically 5-25 μl) are initially time-based aspirated sequentially into the holding coil where they 
are stacked one after the other. Afterwards, the selection valve is switched to the outlet port (here 
position 5), and the segments are propelled forward towards the detector, undergoing on their way 
dispersion and thereby partial mixing with each other, and hence promoting chemical reaction, the 
result of which is monitored by the detector. Notable advantages of SI as compared to FI are in 
particular that it allows the exact metering of even smaller volumetric volumes (of the order of a 
few microlitres), which fostered the use of liquid enzymes (49,50) and costly cofactors as demanded 
in NAD-linked enzymic assays (40). Further, thanks to the use of a syringe pump, SI is much better 
suited for stopped-flow procedures where a very precisely selected delay time is necessary, and that 
it readily and reproducibly permits flow reversals, which, in fact, in addition as a mere means of 
transport, also might be used to promote mixing of sample and reagent(s) and facilitate controlled 
sample dilution within the HC.   
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Besides, it is extremely economical as to consumption of sample and reagents, and hence in waste 
generation, which nowadays is an important parameter since it is becoming increasingly expensive 
to dispose of chemical wastes. And since all manipulations are computer controlled, it is easy and 
simple to reprogram the system from one application to another one, providing great versatility for 
monitoring multiple variables in fermentation broths (12,37) since all operating protocols such as 
sample injection, mixing, and separation are controlled precisely by the software without need for 
physical reconfiguration of the system. However, it is generally difficult to accommodate (stack) 
more than two reagents along with the sample, although additional reagents might be added further 
downstream, i.e., by making an FI/SI-hybrid. And due to the use of a syringe pump, SI has a 
somewhat limited operating capacity, although this in practice rarely is a constricting factor. 
 
Allowing the communication to various peripheral ports at will, SI has proven itself especially 
useful for monitoring of fermentation processes as facilitated by automated recalibration of the 
system, injection of quality control standards, performing of standard addition methods, injection of 
samples from different sampling sites with variable time basis and real-time calculation of actual 
concentrations of substrates and products as well (27,51). Besides, it has found notable use in 
pharmaceutical industries, allowing not only for analysis of drug formulations, but particularly 
facilitating monitoring of drug-dissolution profiles, in-vitro drug-release testing and functional 
assays for screening of potential drugs (52-54).   
 
 
X.6 Microfluidic Devices: Lab-on-Valve 
In the Lab-on-Valve (LOV) concept (Fig. 1(c)) advantage is taken of using an integrated 
micromachined structure (5). The microconduit monolith (which has a diameter of ca. 5 cm, a 
thickness of ca. 10 mm; a photo of it is shown in Fig. 5(a)), made initially of Perspex, but more 
recently of hard polyvinylchloride, polyetheretherketone (PEEK) or polyetherimide (ULTEM) for 
improved chemical resistance to a wide range of organic solvents, is mounted atop of a six- or ten-
port selection valve. Allowing further downscaling of conventional SI systems, and designed to 
incorporate all necessary laboratory facilities for a variety of analytical chemical assays, hence the 
name lab-on-a-valve, it is made to contain mixing points for sample and reagents; working channels 
for sample dilution, overlapping of zones, sample and reagent(s) incubation and sample 
purification; and, to the extent possible, a multipurpose flow-through cell for real-time monitoring 
of the development of the chemical reactions (55). Thus, the LOV unit can readily be devised to 
incorporate optical detection facilities, that is, devices (namely, diode-array spectrophotometers, 
USB charged-coupled devices (CCDs), laser-induced spectrofluorimeters or luminometers) where 
the communications to the detector and/or the light source are made via optical fibres (Fig. 5(b)), 
and where the position of the fibres can be used to adjust the optical light path of the cell (5). 
Electrochemical detection has been recently proven feasible by use of the flow-through cell for 
housing a three-electrode voltammetric unit (16). The microfabricated channel system (typically 1.6 
mm i.d.) is also amenable to admit conventional sized peripheral devices, thus facilitating the 
hyphenation with a plethora of optical detection techniques and modern analytical instruments (Fig. 
5(a)), such as electrothermal atomic absorption spectrometry (56), inductively coupled plasma-
atomic emission spectroscopy or mass spectrometry (57), cold-vapor atomic absorption 
spectrometry (58), electrospray ionization mass spectrometry (59,60), atomic fluorescence 
spectrometry (61), and, what is especially important for bioseparations and cell technology, to 
chromatographic/electrophoretic column separation systems coupled to UV-Vis or mass 
spectrometric detection for multiparametric assays (62-64). Thus the role of the LOV is here to 
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serve as a “front end” to execute appropriate sample pretreatments aimed at introducing the analyte 
optimally into the detection instrument. 
  
A valuable asset of the microflow structure is the microfluidic handling of not only metered 
volumes of solutions but solid suspensions as well for exploitation of heterogeneous chemical 
reactions (Fig. 5(b)). The LOV approach fosters the in-valve manipulation of sorbent materials 
carrying suitable surface moieties in order to generate packed column reactors for micro-scale solid-
phase extraction (65,66), or microaffinity chromatography (67), in a permanent or a renewable flow 
fashion, that is, the so-called bead-injection (BI) scheme (68,69), depending on the particular 
chemical assay. In short, microcolumns are in-situ generated by aspirating beads with particular 
surface characteristics and particle sizes, advantage being taken of the fact that the sorbent can be 
manipulated exactly as when handling liquids. The solid entities can even be automatically 
transported between different column positions within the LOV, their retention within the columns, 
as reported elsewhere (65), being facilitated by fitting the column positions with appropriate 
stoppers (Fig. 5(a)), which will keep hold of the beads, yet allow solutions to flow freely. Following 
sample loading and clean-up protocols, appropriate eluents can be aspirated, and the eluate 
propelled to either the flow-through cell or an external detection device, as sandwiched by air or 
immiscible liquid segments in order to preserve its integrity (70,71).  
 
In order be operated in the BI-LOV fashion, there are some requirements to the bead materials, that 
is, they should be perfectly spherical (i.e., in the form of globe-shaped particles; they should be 
uniform in size distribution (falling within a range of 40-150 μm); and they should possess a density 
close to that of water. Nowadays, a wide array of bead particles (predominantly with a core of 
Sephadex type copolymers) with various surface characteristics are commercially available, and in 
the following section will be described procedures for real-time monitoring of cellular activities via 
immobilized live cells (15,72), isolation and on-column fluorimetric detection of DNA (15), 
optimization of immobilization protocols for proteins (74), as well as investigation of biomolecular 
association and dissociation processes as exploited in enzyme-linked immunosorbent assays (75) 
and affinity chromatographic methods (59,60,76). Yet before that, it might be of interest to compare 
the LOV with the socalled micro-total analysis systems (μTAS) (77), or as they lately have been 
termed Lab-on-a-Chips (LOC), which are exploited for bionanotechnological applications (78,79).  
 
The interest for μTAS/LOC microstructures was actually stimulated in the early 90’s by electrical 
and mechanical engineers, who parallelly and intensively focused on miniaturisation of flow 
devices (77). The channel network, which is made by various sophisticated procedures, such as 
micro-drilling, etching, photolithography, or laser erasing, is impressively exact and reproducible, 
allowing different channels profiles to be obtained. In many instances it can be made in inexpensive 
materials, namely silicon, glass, polymethyl methacrylate and polydimethylsiloxane, and mass-
produced at low cost, in fact, at much lower expenditures than the LOV. However, the microfluidic 
devices are usually dedicated, that is, they have fixed architecture for predetermined chemistries. 
However, as opposed to what applies for LOC systems, LOV practitioners are not being dictated by 
a fixed architecture of their microfluidic devices in order to implement chemical assays, but are able 
to control the parameters at will in order to adapt the physical movements of the liquids to the 
chemistries to be implemented. This, very importantly, implies that they can intelligently exploit the 
interplay between thermodynamics and kinetics, which is of utmost relevance when dealing with 
chemistries that are not fast or instantaneous, or even require stepwise reaction sequences. In this 
context it is interesting to note that the authors of microfluidic devices are customarily 
demonstrating the capacity of their LOCs for fast, single step bioassays (80,81), which leaves a 
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multitude of very interesting and intriguing chemistries unexplored. Further, the small dimensions 
of the microchip channels pose a severe problem for sensitive and reliable absorbance 
measurements (82). 
  
Further, LOV practitioners possess the ability to manipulate the conditions in such a manner that the 
axial dispersion is minimized at the expense of the radial dispersion, thereby ensuring good mixing 
of sample and reagent within the individual microfluidic segments. This can readily be 
accomplished by destabilising the laminar flow pattern via the geometry of the flow conduit, e.g., 
the sample/reagent path is made to be nonlinear and/or non-uniform in diameter (5, 83), and, as 
opposed to LOCs, by designing appropriate flow programming protocols which might comprise 
flow reversals, flow acceleration, stopped flow and bursts of high flow velocity. These tools 
promote fast radial mixing, while axial mixing is controlled by choice of the injected volumes, and 
by the length travelled by the plug in forward and reversed direction. Since incubation times are 
promoted by stopping the flow (either in the holding coil or better yet in the LOV flow-through 
cell), the length of the conduit through which the sample will travel can be minimized. At the same 
time, by increasing the conventional narrow flow channels in LOCs from 10-100 μm up to 1.6 mm 
in LOV, the surface to volume ratio in LOV is reduced, thus minimizing adsorption of 
macromolecules on the walls of the microbore conduit. In addition, the low flow resistance of short 
and wide flow conduits allows precise flow manipulation, and the use of ultra fast bursts of flow 
that can wash out the channels rapidly and easily remove stray air bubbles or clogging particles. 
Readers are referred to a recently published comprehensive review article for a detailed and critical 
comparison of LOV and LOC micromachined units (84). 
 
In the following are detailed a few practical examples of using the SI-LOV approach for 
biochemical assays and bioseparations.  
 
 
X.7 Selected Bioanalytical Applications Exploiting  SI-LOV  
 
X.7.1 Exploiting the Stopped-Flow Approach 
As mentioned earlier, the stopped-flow technique (Fig. 2) is a very powerful tool for determining 
analyte species participating in enzymatic or cellular assays (14). Relying on manipulating the 
concentrations of the constituents participating in the chemical reaction so that these can be 
considered constant during the measurement (for instance by recording absorbance as depicted in 
Fig. 2), that is, pseudo-zero reaction conditions are met (dC/dt = k’C, where C is the concentration 
of analyte), the slope of a plot of the analytical signal (in casu Absorbance) against the time will be 
directly proportional to the concentration of analyte. At least within a certain time frame, which is 
also why the procedure is termed measurement of initial reaction rates. In practice, the progression 
in the recorded detector signal (Δsignal) over a fixed period of time (Δt) is used. Furthermore, the 
plot will directly reveal within which range the reaction conditions are fulfilled (i.e., slope is 
constant), and which time interval thus is applicable for measurement. An added and unique 
advantage of this approach is that automatic blanking is obtained, because only the generated signal 
(Δsignal) within in the time interval is utilised for quantification. When incorporated within the 
LOV format, where very minute consumptions of sample and reagents are required, and where one 
can take advantage of the extremely accurate operation of the incorporated syringe pump for 
aspiration and propelling of solutions, the approach presents itself as an ideal solution for process 
monitoring of both large and small scale bioreactors (5,85). 
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Several LOV-applications of the stopped-flow approach have appeared in the literature. Thus, with 
an LOV system as that depicted in Fig. 5(b) and using detection by spectrophotometry, Wu et al. 
(60) employed it for monitoring ammonia, glycerol, glucose and free iron in a fermentor, while 
Chen and Ruzicka (18) used it for determination of glucose and ethanol. While the glucose assay 
was based on catalytic degradation of glucose oxidase leading to the generation of hydrogen 
peroxide, which was subsequently reacted with 4-aminoantipyrine to form a quinoneimine dye (18), 
ammonia was assayed via the Berthelot indophenol blue method with salicylate and hypochlorite as 
reagents. In Fig. 6 is shown the sequence of the aspirated sample and reagents, where NH3 
represents the sample, the reagent is salicylate, while the spacer is a plug of carrier solution (diluted 
aqueous solution of detergent) inserted for promoting sufficiently partial mixing of sample and 
reagents and allowing a suitable delay time before the stopped-flow measurements. As shown in the 
lower part of the Fig. 6, the stopped-flow readouts are very reproducible.   
 
X.7.2 Bioseparations and Cellular Assays 
Combining LOV and bead injection (BI), Ruzicka and coworkers have in particular focused on 
cellular analyses and immunoassays (15,67,74-76). The former are being used for screening of 
potential drugs by in-vitro evaluation of biological responses. Cells are cultivated onto 
polysaccharide microbeads and thus a representative number of cells within the LOV is ensured 
using a minute volume of bead suspension. Cellular responses are evaluated by determination of 
different parameters, such as release of cytosolic calcium, intracellular or extracellular pH (15) 
metabolic oxygen consumption (16), lactate extrusion (72) or glucose consumption (86). 
 
Immunoassays have been miniaturised within microfluidic devices for quantification of 
biomolecules by either monitoring them as they are captured on microbeads bearing antigen species 
as entrapped within the LOV flow cell via UV/VIS spectrophotometry or fluorometry  (see Fig. 7A) 
or by detecting them as they are eluted from the beads (Fig. 7B). While the first approach can be 
viewed as “on-column spectroscopy” (15,74,75), the latter one can be considered as miniaturized 
bioaffinity chromatography (59,60,67). Both methods employ in-valve bead injection analysis with 
renewable microcolumns and identical analytical instrumentation, whereby they can be exploited in 
a complementary fashion to get further knowledge on biomolecular association and dissociation 
reactions (76,88). The microaffinity chromatography in the LOV format has been demonstrated for 
separation of immunoglobulins or nucleic acids, as based on molecular recognition between a site 
fixed on the stationary phase and the target species that is being captured, while unwanted matrix 
components, such as salts and proteins, are washed out by the mobile phase. In contrast to 
conventional immunoaffinity chromatography it is readily feasible to control the operational pH, 
which is a very critical parameter, and compared to on-column spectroscopy, LOV-chromatography 
on a renewable bead column is more robust, since the volume of the beads captured within the 
microcolumn is far less critical, and also because the target analyte is eluted and monitored in 
solution and not on bead surfaces, thus precluding light scattering effects (67,76). Furthermore, by 
using a short pulse of eluant, the front elution contains almost all target molecules, yielding 
excellent limits of detection. Yet, the most severe limitation of microaffinity chromatography is that 
it cannot monitor antibodies when remaining immobilized irreversibly on the bioligand bearing 
beads. On the contrary, bead injection spectroscopy monitors the sorption process, whereby the 
elution of target species is not a must since beads can be automatically withdrawn following 
recording of the spectroscopic readout (74,76). 
 
In this context it should also be mentioned that the SI-LOV system has been interfaced to capillary 
electrophoresis (CE) with UV detection for inorganic anion and protein separation (62,63). In this 
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case, the multi-purpose flow cell was reconfigured to act as a front end between the microfluidic 
device and the CE separation module. The microfluidic property of LOV did not merely provide an 
efficient sample delivery conduit for the CE system with various sample injection modes, including 
electrokinetic, hydrodynamic and head column field amplification sample stacking (98), but at the 
same time served as a versatile means of sample pretreatment and chemical derivatization (e.g., 
protein labelling) (63) to facilitate the ensuing CE separation. 
 
A detailed compilation of the work by Ruzicka and his coworkers can be found on the CD-ROM 
published by Ruzicka (89). 
 
 
X.7.3 DNA Assays 
A very active research group at Northwestern University in Shenyang, China, headed by Professor 
Jianhua Wang, have over the past few years published a series of papers focused on determination 
and/or purification of DNA exploiting the inherent features of LOV. In the first communication 
(90), and using a LOV similar to the one shown in Fig. 8, they described a spectrophotometric 
procedure for DNA assay, where a small amount of crystal violet solution (10 μl) was de-coloured 
inside the flow cell of the LOV in the presence of 5 μl λ-DNA/HindIII within a certain pH range, 
the decrease in absorbance of the crystal violet solution being measured at 591 nm via optical fibers 
and employed as the basis of quantification. Obtaining a detection limit of 0.07 μg ml−1, this work 
was supplemented by a procedure based on fluorescence measurement (91), where sub-nanoliter to 
a few micro-liters of DNA sample and ethidium bromide (EB) solutions were introduced into the 
LOV, resulting in the formation of a DNA–EB adduct, which afterwards was excited in the versatile 
flow cell of the LOV by a 473 nm laser beam, the emitted fluorescence being monitored in-situ via 
optical fibers. By using this approach the detection limit was further decreased, that is, to 0.006 μg 
ml-1 by affixing the aspirated sample volume to 2.0 μl. 
 
In a very recent publication (92), this research group has exploited the LOV for DNA 
separation/purification via solid-phase extraction with a silica microcolumn packed within an LOV 
microchannel. By proper selection of the sample loading and the elution media, the complex matrix 
components in human whole blood, including proteins, could be completely eliminated. The DNA 
purification process was monitored on-line by using laser-induced fluorescence at 610 nm in a 
demountable side part of the LOV unit incorporating optical fibers (Fig. 8). The practical 
applicability of the entire system was demonstrated by separation/purification of λ-DNA in a 
simulated matrix and human blood genetic DNA by performing in-valve SPE, in situ monitoring of 
the purified products via in-situ fluorometric detection of DNA-EB, and postcolumn PCR 
amplification. It was demonstrated to offer significant advantages over chip-based 
separation/purification systems based on the same principle in terms of precision, sampling 
frequency as well as robustness. The employment of the bead injection technique facilitated 
automatic injection and withdrawal of the solid phase material in the LOV-based purification 
system, as opposed to lab-on-a-chip microdevices where renewal of solid substrates is not feasible 
and thus the entire microchip should be discarded and replaced by a new one after short term 
operation. 
  
The Chinese group (93) and the one headed by Professor Luque de Castro (94) in Spain have most 
recently compiled comprehensive reviews on bioanalytical applications of LOV, including cellular 
analysis, immunoassays, affinity chromatography, DNA separation/purification, and enzymatic 
assays. Readers are encouraged to consult these articles for further details. 
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X.8 Conclusion and Perspectives 
Being based on transient measurements and exact and reproducible timing, FIA and its sequels SIA 
and LOV have turned out to open an array of novel possibilities within bioanalytical sciences. A 
compilation of recently published automatic procedures for monitoring of fermentation broths are 
presented in Table 2. Although not exhaustive, it gives a rather good impression of the variability of 
the species determined and the techniques applied. In general it should be stressed that not only do 
the procedures consume very small amounts of sample and reagent solutions, and thus lead to 
generation of minute volumes of waste, but, more importantly, they allow entirely new and unique 
approaches to be implemented, which are not possible with conventional batch or continuous flow 
procedures. 
 
The ultimate goal in modern (bio)chemical analysis is to identify individual analyte species in a 
given complex sample with sufficient selectivity and sensitivity which, in turn, often calls for 
appropriate sample pretreatments or hyphenation of various selective detectors. Such schemes 
might entail physical/temporal separation of individual compounds via chromatographic or 
electrophoretic techniques for speciation purposes or coupling of enzyme-based sensors in series, 
but might also involve the separation of the analytes from potentially interfering matrix 
constituents, or the execution of sample preconcentration protocols. Or, in fact, as most often 
encountered in practice, a combination of all strategies. Here the SI-LOV approach presents itself as 
an ideal vehicle to act as the ‘heart’ of the system, because it is totally automated, miniaturised and 
fully computer-controlled. In SI-LOV, one has the advantage of being able to attach external units 
to facilitate individual operations, such as chromatographic columns for spatial separation of 
individual (bio)components, or for applying external energy sources such as UV light, or ultrasound 
or microwave radiation in order to effect desired reactions. But most importantly, a proper 
hyphenation will allow the implementation of intelligent chemistries, where advantage can be taken 
by the fact that the on-line systems operate under dynamic conditions so that one can exploit the 
interplay between thermodynamics and kinetics. Thus, what is needed in future applications is a 
realisation of what this interplay implies, particularly in terms of facilitating determination of 
(bio)chemical species in culture media or live cells, because this is exactly what differentiates the 
on-line LOV microanalysers from their batchwise counterparts – and, in fact, the LOCs.    
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Figure legends 
 
Fig. 1. (a) Flow injection system, where the sample (S) is injected into a carrier stream as propelled 
by a peristaltic pump (PP), which downstream is merged with reagent(s), the transient signal from 
the product generated by passing the reaction coil(s) (R) being measured by a suitable detector (D). 
(b) Sequential injection system as based on using a selection valve, the central communication 
channel (CC) of which can be programmed to address each of the external ports. Via the central 
communication line (CL), sample and reagents can by means of the syringe pump be aspirated into 
the holding coil and afterwards propelled to the detector which monitors the ongoing chemical 
reaction. (c) Lab-on-valve (LOV) system, the concept of which is a microconduit placed atop a 
selection valve (as shown in Fig. 5). Ideally containing all means for facilitating the chemical assay, 
including a flow-through detection cell, the microconduit is also amenable to externally attached 
components, such as detectors or bead reservoirs for integrating small packed column reactors.      
 
Fig. 2. (a) Simple stopped-flow FI-manifold, where the timer (T) can be set to stop the liquid 
stream at a preset time. (b) As demonstrated for a spectrophotometric measurement of absorbance, 
curve (A) shows the signal for continuous pumping, curve (B) for a fast (instantaneous) chemical 
reaction), while the dashed line (C) indicates the signal output that would be registered if a zero-
order or pseudo-zero-order reaction had taken place within the stop interval. From ref. 14, courtesy 
John Wiley & Sons.        
 
Fig. 3. (a) FI-manifold for the detection of glucose with an amperometric sensor to detect 
enzymatically generated hydrogen peroxide; (b) Calibration graphs for glucose in the concentration 
range 0-40 mmol/L at three different flow rates: (Δ) 0.50, (▲) 0.75, and (x) 1.00 mL/min. 
From ref. 28, courtesy Taylor & Francis. 
 
Fig. 4. Typical course of light generation (hν) in a bio- or chemiluminescent reaction as a function 
of time. Quantification can be accomplished either by relating the amount of analyte to the energy 
released (i.e., integrating the area under the curve), or by using FI and determining the intensity 
(dE/dt) after a fixed period of time (Δt), which, if pseudo-first reaction conditions are fulfilled (cB 
>> cA), is directly proportional to the concentration of the analyte (A).  
 
Fig. 5. (a) Close-up of LOV system for bead injection (BI) incorporating two microcolumn 
positions (C1 and C2), along with a diagram of a packed renewable microcolumn (from ref. 55, 
courtesy Elsevier Science Publishers). (b) Schematic diagram and magnified close-up of an SI-LOV 
microsystem incorporating a multipurpose flow cell configured for measurement of absorbance. 
Adapted from ref. 86, courtesy Royal Society of Chemistry.   
 
Fig. 6. (a) Sequence of the stacked zones of sample, reagents and spacer for the determination of 
ammonia. (b) Stopped-flow readouts as shown in triplicate for different concentrations (0-1200 
ppm) of ammonia, revealing the high reproducibility of measurements. The hatched rectangles 
indicate the stopped-flow measuring periods. From ref. 89, courtesy of the author.  
 
Fig. 7. Experimental setup for bead injection spectroscopy and micro-affinity chromatography. At 
the bottom is shown in (A) the configuration of the flow cell for capturing and monitoring of beads 
by UV-Vis spectrophotometry; and in (B) the configuration of the flow cell for micro-affinity 
chromatography. The beads are retained as a microcolumn by a sheath of optical fiber, designed to 
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allow the mobile phase to pass freely into the flow cell (light path 10 mm). From ref. 89, courtesy of 
the author. 
 
Fig. 8. LOV system employed for DNA separation and purification from human blood, integrating 
a demountable fluorescence flow cell. EB, ethidium bromide; LIF, laser-induced fluorescence; P1 
and P2, peristaltic pumps; SP, syringe pump; V1, three-way valve; and C1 and C2, micro columns. 
From ref. 92, courtesy of Springer Science and Business Media.  
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Table 1. Examples of FIA gradient techniques 
_____________________________________________________________________________ 
Gradient dilution 
Selecting and using for the analytical readout specific fluid elements along the 
concentration gradient, the concentration being C = Co/D(ti). To be used, for instance, to 
accommodate the concentration of sample to the dynamic range of a detector. 
Gradient calibration 
Identifying and exploiting a number of elements along the gradient, the concentrations of 
which are given through the dispersion coefficient of the individual elements. A multipoint 
calibration curve can be obtained from a single injection of a concentrated sample. 
Gradient scanning 
Combining the use of gradient dilution with the use of a dynamic detector which, for each 
concentration level, is able continuously to scan a physical parameter, such as wavelength or 
potential.  
Stopped-flow 
Increase of sensitivity of measurement by increasing residence time, or quantifying sample 
concentration by measuring a reaction rate under pseudo-zero-order reaction conditions (see 
Fig. 2).  
Titration 
Identifying elements of fluids on the ascending and descending parts of the concentration 
gradient where equivalence between titrand and titrant is obtained, and relating the time 
difference between these elements to the concentration of injected analyte. 
Penetrating zones 
Exploitation of the response curves from the concentration gradients formed when two or 
more zones are injected simultaneously. In addition to acting as an economical way of 
introducing sample and reagent solutions, it can be used for measuring selectivity 
coefficients, and to make standard addition over a wide, controllable range of 
standard/analyte concentration ratios.                    
_____________________________________________________________________________ 
 
Table 2. Analytical performance of selected flow methods involving enzymic reactions for monitoring fermentation and culture broths  
 
 
   
 
Analyte(s) Microorganism Flow 
approach 
Detection 
technique 
Linear range Detection limit Precision   
(RSD, %) 
Reference 
Glucose and 
ammonia 
Penicillium 
chrysogenum 
FI SP 
(ammonium)  
CL (glucose) 
5-700 mg L-1 
(glucose) 
0-10.8 mg L-1 
(ammonium) 
5 mg L-1 
(glucose) 
NR (ammonium) 
< 2 (glucose) 
NR 
(ammonium) 
10 
Glucose and 
ethanol 
NR SI Amp 5-750 mg L-1 
(glucose) 
0.15-30 mg L-1 
(ethanol) 
15 µg L-1 (H2O2) < 1.2 (glucose) 
< 2.2 (ethanol) 
12 
Ethanol Saccharomyces 
cerevisiae 
 
FI/SI Amp 0.05-11.5 mg L-1 50 µg L-1 7.4 22 
Glucose and L-
lactate 
Lactobacillus 
casei 
 
FI Amp 2-100 g L-1 
(glucose) 
1-60 g L-1 (lactate) 
2 g L-1 (glucose) 
1 g L-1 (lactate) 
NR 23 
Lactic acid Mammalian cell 
293S (kidney) 
FI Amp 0- 0.27 g L-1 4.5 mg L-1 1.5 24 
Glucose and L-
lactate 
Lactococcus 
lactis 
 
FI Amp 0.01-0.1 g L-1  
(glucose) 
0.01-0.5 g L-1 
(lactate) 
10 mg L-1 
(glucose and 
lactate) 
 
NR 25 
Glucose, 
ethanol and 
glutamate 
Torulopsis 
versatilis 
 
FI Amp 5-50 g L-1 (glucose 
and ethanol) 
1-20 g L-1 
(glutamate) 
 
5 g L-1 (glucose 
and ethanol) 
NR 
1 g L-1 
(glutamate) 
33 
Analyte(s) Microorganism Flow 
approach 
Detection 
technique 
Linear range Detection limit Precision 
(RSD, %) 
Reference 
Glutamine 
and glutamate 
Mammalian cell 
culture 
FI SP 0-0.44 g L-1 
(glutamate) 
0-1.0 g L-1 
(glutamine) 
NR < 1 (glutamate 
and glutamine) 
34 
Glucose Animal cells 
(Langerhans islets), 
Escherichia coli and 
Saccharomyces 
cerevisiae 
 
FI Amp 0-1.1 g L-1 10 mg L-1 1 35 
Glucose, 
lactic acid, 
penicillin 
Penicillium 
chrysogenum 
SI CL 0-100 mg L-1 
(glucose, penicillin 
and lactic acid) 
 
5 mg L-1 (glucose 
and lactic acid) 
10 mg L-1 
(penicillin) 
2.06 (glucose) 
2.56 (lactic 
acid) 
< 2 (penicillin) 
37 
Glucose, 
lactate, 
ethanol, 
galactose, L-
aminoacids 
Mesenchymal stem 
cells, Escherichia 
coli and 
Saccharomyces 
cerevisiae 
 
FI SP 0-1.5 g L-1 
(glucose) 
0-1.2 g L-1 
(ethanol) 
0-0.42 g L-1 
(lactate) 
0-5 g L-1 (L-
leucine) 
11 mg L-1 
(glucose) 
16 mg L-1 
(ethanol) 
5 mg L-1 (lactate 
and L-leucine) 
< 1 39 
D-lactic acid Lactobacillus 
delbrueckii 
 
SI SP 0.18-2.25 g L-1 90 mg L-1 NR 40 
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Analyte(s) Microorganism Flow 
approach 
Detection 
technique 
Linear range Detection limit Precision 
(RSD, %) 
Reference 
Glucose, 
lactose, 
galactose, lactic 
acid 
Streptococcus 
cremoris 
 
FI 
23
 
Abbreviations: FI, Flow Injection; SI, Sequential Injection; LOV, Lab-on-a-Valve; SP, Spectrophotometry; Amp, Amperometry; CL, 
Chemiluminescence; RSD, Relative standard deviation; NR: Not reported.
CL 1-2000 mg L-1   
(glucose) 
3-3000 mg L-1 
(galactose) 
0.025-5000 mg L-1 
(lactose) 
0-8000 mg L-1  (lactic 
acid) 
5 mg L-1 (glucose) 
3 mg L-1 
(galactose) 
0.1 mg L-1 (lactose) 
0.1 mg L-1 (lactic 
acid) 
≤1 (glucose, 
galactose, and 
lactose) 
2 (lactic acid) 
41 
Methanol Pichia pastoris SI SP 0-2 g L-1 0.12 g L-1 < 4 50 
Ammonium, 
glucose, 
glycerol and 
free iron 
Escherichia 
coli 
LOV SP 86 0.9 (ammonia) 
1.5 (free iron) 
1.1 (glycerol 
and glucose) 
(glucose) 
3-1200 mg L-1 
(ammonia) 
20-120 mg L-1 
(glycerol) 
35-1000 mg L-1 
(glucose) 
80-400 mg L-1 (free 
iron) 
3 mg L-1 
(ammonia) 
20 mg L-1 
(glycerol) 
80 mg L-1 (free 
iron) 
35 mg L-1 
 
 
